Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Rauch

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Autoimmunity|January 28, 2015
Autoimmunity and antibody affinity maturation are modulated by genetic variants on mouse chromosome 12Roxanne Collin, Véronique Dugas, Geneviève Chabot-Roy, et al.
Ejhaem|February 23, 2023
Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell diseaseClaudia Rodriguez Rivera, Andrew Srisuwananukorn, Rizma Jalees Bajwa, et al.
Arthritis Research & Therapy|January 14, 2022
Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritisNatalia Regine de França, Henri André Ménard, Maximilien Lora, et al.
Autoimmunity|October 9, 2009
Apoptotic and necrotic cells as sentinels of local tissue stress and inflammation: response pathways initiated in nearby viable cellsVimal A Patel, Daniel J Lee, Angelika Longacre-Antoni, et al.
Journal of Translational Autoimmunity|February 18, 2026
Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus modelJerrold S Levine, Céleste Pilon, Rebecca Subang, et al.
Thrombosis and Haemostasis|December 8, 2004
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosisJeannine Kassis, Carolyn Neville, Joyce Rauch, et al.
The Journal of Rheumatology|December 17, 2003
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodiesMarie Hudson, Andrée-Laure Herr, Joyce Rauch, et al.
The Journal of Rheumatology|August 16, 2002
Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodiesNikhil Chopra, Sharon Koren, Wenda L Greer, et al.
The Journal of Biological Chemistry|July 18, 2015
Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy storesVimal A Patel, Donald Massenburg, Snezana Vujicic, et al.
The Journal of Biological Chemistry|December 27, 2005
Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunityVimal A Patel, Angelika Longacre, Kevin Hsiao, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Autoimmunity|January 28, 2015
Autoimmunity and antibody affinity maturation are modulated by genetic variants on mouse chromosome 12Roxanne Collin, Véronique Dugas, Geneviève Chabot-Roy, et al.
Ejhaem|February 23, 2023
Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell diseaseClaudia Rodriguez Rivera, Andrew Srisuwananukorn, Rizma Jalees Bajwa, et al.
Arthritis Research & Therapy|January 14, 2022
Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritisNatalia Regine de França, Henri André Ménard, Maximilien Lora, et al.
Autoimmunity|October 9, 2009
Apoptotic and necrotic cells as sentinels of local tissue stress and inflammation: response pathways initiated in nearby viable cellsVimal A Patel, Daniel J Lee, Angelika Longacre-Antoni, et al.
Journal of Translational Autoimmunity|February 18, 2026
Type I interferon-dependent and -independent signaling underlie autoantibody production in a murine lupus modelJerrold S Levine, Céleste Pilon, Rebecca Subang, et al.
Thrombosis and Haemostasis|December 8, 2004
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosisJeannine Kassis, Carolyn Neville, Joyce Rauch, et al.
The Journal of Rheumatology|December 17, 2003
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodiesMarie Hudson, Andrée-Laure Herr, Joyce Rauch, et al.
The Journal of Rheumatology|August 16, 2002
Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodiesNikhil Chopra, Sharon Koren, Wenda L Greer, et al.
The Journal of Biological Chemistry|July 18, 2015
Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy storesVimal A Patel, Donald Massenburg, Snezana Vujicic, et al.
The Journal of Biological Chemistry|December 27, 2005
Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunityVimal A Patel, Angelika Longacre, Kevin Hsiao, et al.
Pageof 5